These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats. Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067 [TBL] [Abstract][Full Text] [Related]
4. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model. Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells and infectious diseases: Smarter than drugs. Mezey É; Nemeth K Immunol Lett; 2015 Dec; 168(2):208-14. PubMed ID: 26051681 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. Kim N; Im KI; Lim JY; Jeon EJ; Nam YS; Kim EJ; Cho SG Ann Hematol; 2013 Oct; 92(10):1295-308. PubMed ID: 23722500 [TBL] [Abstract][Full Text] [Related]
7. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect. Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849 [TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Zhao S; Wehner R; Bornhäuser M; Wassmuth R; Bachmann M; Schmitz M Stem Cells Dev; 2010 May; 19(5):607-14. PubMed ID: 19824807 [TBL] [Abstract][Full Text] [Related]
11. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience. Conklin LS; Hanley PJ; Galipeau J; Barrett J; Bollard CM Cytotherapy; 2017 Jun; 19(6):655-667. PubMed ID: 28433516 [TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic applications of mesenchymal stromal cells. Larsen S; Lewis ID Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470 [TBL] [Abstract][Full Text] [Related]
13. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model. Li ZY; Wang CQ; Lu G; Pan XY; Xu KL Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072 [TBL] [Abstract][Full Text] [Related]
14. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease. Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216 [TBL] [Abstract][Full Text] [Related]
15. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice. Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses. Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448 [TBL] [Abstract][Full Text] [Related]
18. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells. Bernardo ME; Locatelli F; Fibbe WE Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238 [TBL] [Abstract][Full Text] [Related]
20. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease. Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]